REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 75.00
Bid: 70.00
Ask: 80.00
Change: 0.00 (0.00%)
Spread: 10.00 (14.286%)
Open: 75.00
High: 75.00
Low: 75.00
Prev. Close: 75.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

30 Jul 2020 07:00

RNS Number : 5306U
Biome Technologies PLC
30 July 2020
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR")

 

30 July 2020

 

 

Biome Technologies plc

 

("Biome", "the Company" or "the Group")

 

Trading Update

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today publishes a trading update for the six months ended 30 June 2020. The Company's unaudited interim results are expected to be announced on 24 September 2020.

 

Total Group revenues for the first half of the year, including government grant income, were £2.6m (H1 2019: £3.6m), in line with the Board's expectations.

 

As anticipated, the Bioplastics division performed well despite the upheaval caused by Covid-19 with a 53% increase in revenues over the same period in the prior year. The revenues of the Stanelco RF division, however, were compromised by both over-capacity in the fibre optic market and the slow-down in industrial activity caused by Covid-19, which remains ongoing.

 

The Group's cash position as at 30 June 2020 was £1.1m (31 March 2020: £1.8m), reflecting Group trading performance and an expected increase in the working capital requirement of the Bioplastics division to support the ongoing growth in that business. The Group has no debt.

 

The Group continues its manufacturing and development operations whilst ensuring the safety of staff and in conformance with Government advice. The Group has continued to make use of the UK Government "furlough scheme" and has curtailed discretionary operational and capital expenditure.

 

Bioplastics Division

 

Revenues in the Bioplastics division continued to grow during H1 2020, reaching £2.2m for the period including government grant income of £0.1m (H1 2019: £1.4m including government grant income of £0.2m). Revenue in the second quarter was £1.2m, slightly above the first quarter and representing a new record for the division, despite the disruption caused by the pandemic.

 

The strong performance in the period was underpinned by increased sales of outer packaging for the USA coffee market and by growing revenues for rigid ring materials for the coffee-pod market. Despite the lockdown and supply chain constraints in both Europe and the USA, the Bioplastics division's work flows proved resilient and production output met customer requirements throughout the first half.

 

We are working with an expanding list of potential new customers in the USA and developmental work in that context continues with some vigour. The business is well positioned to exploit further opportunities in this growing market.

 

The division's medium-term research activities in Industrial Biotechnology continue, which include the development of a new range of performance polymers with properties which are expected to improve the existing generation of products. This work, taking place at the universities of Nottingham and York, is supported by government grants. Whilst university closures have slowed this work, post period end, the division has received an Innovate UK Continuity Grant of £63,000 to support the recovery of time lost on this work.

 

Stanelco RF Technologies Division

 

Revenues for the first half of 2020 in the Stanelco RF division were £0.4m (H1 2019: £2.2m).

 

A substantial proportion of the Stanelco RF division's revenues are normally derived from the production and maintenance of furnaces for the manufacture of fibre optic cable. Overcapacity in the fibre optic cable market, apparent from late 2018, has been exacerbated by the pandemic as telecommunication companies have suffered restrictions on cable deployment activity and international trade disputes have slowed the deployment of 5G. These factors have led to temporary shut-downs of a number of manufacturing facilities at Stanelco RF's customers, with a consequential reduction in the requirement for Stanelco RF to provide equipment, spares and service support. The expectation is that in the long term, the fibre optic market will benefit from the pandemic through the enhanced pace of global digitisation required to meet the demands of, for example, increased home working and the 5G roll-out. However, in the short term, demand is likely to remain weak.

 

The division also provides induction heating and welding equipment to various end markets in the UK and continental Europe. Activity in these markets in the second quarter was very weak, with many facilities closed and customers deferring the purchase of capital goods. The Company is pleased that in the last few weeks, the enquiry level has increased and there have been some small contract wins albeit overall demand levels remains subdued.

Outlook

 

The Board has sought to provide investors with as clear a view as possible on its expectations for the Company during this exceptional year. During the first half of 2020, the Group's two divisions performed in line with the expectations communicated and considered appropriate by the Board in April 2020, during the early stages of the Covid-19 pandemic.

 

The Bioplastics division now has a range of products with a more predictable and improving growth profile and is selling in the USA predominantly, into a buoyant home-delivered coffee sector. Its orderbook now extends further forward than the division has ever experienced before, and the Board is therefore confident on the outlook for the Bioplastics division for the remainder of the current financial year.

 

Covid-19 has had a much greater impact on the Stanelco RF division. The fibre optic cable market remains oversupplied and the current pace of recovery in demand in the industrial goods sector now appears slower and more uncertain than was anticipated in April 2020. Whilst refilling of the division's orderbook has begun in a modest manner, significant further momentum would be required in the second half of the year to meet the expectations previously set by the Board. As a result, the Board has concluded that it is necessary to revise downwards the revenue expectations for the Stanelco RF division for the second half of the year.

 

 

 

- Ends -

 

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

David Hughes, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and that are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

 

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited. Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers. Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets

 

www.biometechnologiesplc.com

www.biomebioplastics.com and www.thinkbioplastic.com 

www.stanelcorftechnologies.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKCBKOBKDQOB
Date   Source Headline
20th Jan 20177:00 amRNSPre-close Trading Statement
18th Jan 20177:00 amRNSSettlement Agreement
2nd Nov 20167:00 amRNSTrading Update
31st Aug 20167:00 amRNSHalf-year Report
27th Jun 20167:00 amRNSTrading Update
25th Apr 201612:34 pmRNSResult of Annual General Meeting
25th Apr 20167:00 amRNSTrading Update
1st Apr 201610:42 amRNSNotice of AGM and Annual Report and Accounts
30th Mar 20167:00 amRNSFinal Results
26th Jan 20167:00 amRNSPre-close Trading Statement
3rd Nov 20157:00 amRNSTrading Statement
2nd Sep 20157:00 amRNSInterim Results
23rd Jul 20157:00 amRNSTrading Update
19th Jun 20159:00 amRNSNew Contract
27th Apr 20154:46 pmRNSResult of AGM
27th Apr 20157:00 amRNSTrading Update
27th Mar 20153:43 pmRNSNotice of Annual General Meeting
25th Mar 20157:00 amRNSPreliminary Results
19th Feb 20153:26 pmRNSFunding Award
29th Jan 20157:00 amRNSOperational Update
22nd Jan 20157:00 amRNSPre-close Trading Statement
21st Jan 20154:35 pmRNSHolding(s) in Company
11th Dec 201410:11 amRNSChange of Adviser
14th Nov 20149:58 amRNSHolding(s) in Company
4th Nov 20147:00 amRNSTrading Update
3rd Sep 20147:00 amRNSInterim Results
12th Aug 20149:36 amRNSHolding(s) in Company
31st Jul 20147:00 amRNSContract progress for RF Technologies Business
24th Jul 20143:28 pmRNSTrading Update
6th Jun 20143:56 pmRNSHolding(s) in Company
7th May 20147:00 amRNSEMI Share Option Plan
23rd Apr 201412:26 pmRNSResult of AGM and Appointment of Director
23rd Apr 20147:00 amRNSTrading Update
31st Mar 20147:00 amRNSUpdated Corporate Presentation
28th Mar 20147:02 amRNSPosting of Notice of AGM & Annual Report
27th Mar 20147:00 amRNSPreliminary Results
24th Mar 201411:43 amRNSContract for Stanelco RF Technologies Division
19th Feb 20149:01 amRNSHolding(s) in Company
24th Jan 20147:00 amRNSPre-close Trading Statement
4th Dec 20133:37 pmRNSIssue of Shares to Director
28th Nov 20131:30 pmRNSDirector/PDMR Shareholding
27th Nov 20137:00 amRNSHolding(s) in Company
4th Nov 20137:00 amRNSTrading Update
31st Oct 201312:27 pmRNSTotal Voting Rights
2nd Oct 201312:47 pmRNSIssue of Shares to a Director
27th Sep 20138:51 amRNSTR-1: Notification of Major Interest in Shares
25th Sep 201312:33 pmRNSResult of General Meeting
2nd Sep 20137:10 amRNSNotice of General Meeting
2nd Sep 20137:00 amRNSInterim Results
26th Jul 20137:00 amRNSPurchase of Shares following Consolidation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.